Novel combined variants of LDLR and LDLRAP1 genes causing severe familial hypercholesterolemia-Reference-Cited by-同舟云学术

Novel combined variants of LDLR and LDLRAP1 genes causing severe familial hypercholesterolemia

Published:2018-10 Issue: Volume:277 Page:425-433
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Alnouri Fahad^ORCID,Athar Mohammad,Al-Allaf Faisal A.,Abduljaleel Zainularifeen,Taher Mohiuddin M.,Bouazzaoui Abdellatif^ORCID,Al Ammari Dalal,Karrar Hussam,Albabtain Monirah

Funder

National Science, Technology and Innovation Plan (MAARIFAH), Kingdom of Saudi Arabia

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference34 articles.

1. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

2. LDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectives;Al-Allaf;Int. Arch. Med.,2010

3. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society;Nordestgaard;Eur. Heart J.,2013

4. Homozygous autosomal dominant hypercholesterolaemia: prevalence, diagnosis, and current and future treatment perspectives;Sjouke;Curr. Opin. Lipidol.,2015

5. US prevalence of familial hypercholesterolemia higher than expected. News and perspective;Harrison;Cardilogy,2016

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potentials of artificial intelligence in familial hypercholesterolemia: Advances in screening, diagnosis, and risk stratification for early intervention and treatment;International Journal of Cardiology;2024-10

2. Identification and functional characterization of two rare LDLR stop gain variants (p.c231*and p.R744*) in Saudi familial hypercholesterolemia patients;PANMINERVA MED;2023

3. Novel LDLR Variant in Familial Hypercholesterolemia: NGS-Based Identification, In Silico Characterization, and Pharmacogenetic Insights;Life;2023-07-11

4. Identification of an LDLR variant in a Chinese familial hypercholesterolemia and its relation to ROS/NLRP3-Mediated pyroptosis in hepatic cells;Journal of Geriatric Cardiology;2023-05

5. Identification of Novel and Known LDLR Variants Triggering Severe Familial Hypercholesterolemia in Saudi Families;Current Vascular Pharmacology;2022-07